TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for CFHR5
check button Gene summary
Basic gene informationGene symbolCFHR5
Gene namecomplement factor H-related 5
SynonymsCFHL5|CFHR5D|FHR-5|FHR5
CytomapUCSC genome browser: 1q31.3
Type of geneprotein-coding
RefGenesNM_030787.3,
Descriptioncomplement factor H-related protein 5factor H-related protein 5
Modification date20141222
dbXrefs MIM : 608593
HGNC : HGNC
Ensembl : ENSG00000134389
HPRD : 06508
Vega : OTTHUMG00000036517
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_CFHR5
BioGPS: 81494
PathwayNCI Pathway Interaction Database: CFHR5
KEGG: CFHR5
REACTOME: CFHR5
Pathway Commons: CFHR5
ContextiHOP: CFHR5
ligand binding site mutation search in PubMed: CFHR5
UCL Cancer Institute: CFHR5
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesHPA,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Liver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)LIHC
Reference showing the relevant tissue of CFHR5
Description by TissGene annotationsTissgsKTS
CNV gained TissGeneKTS
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for CFHR5

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
LIHC8.234191949.68788394-1.4536920.008340.017983631


Top
TissGene-miRNA for CFHR5

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for CFHR5
TissGeneSNV for CFHR5

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.D559NSKCM3
p.S112FSKCM3
p.R465HCESC2
p.E300KSKCM2
p.D535NSKCM2
p.S67FSKCM2
p.S152LSKCM2
p.P50SSKCM2
p.E73KSKCM2
p.R517KSKCM2
p.E276KSKCM2
p.S128LUCEC2
p.W340*SKCM2
p.S89FSKCM2
p.R465LLUAD1
p.W67*UCEC1
p.Q213LGBM1
p.P401TLUAD1
p.V205IUCEC1
p.H253RBLCA1
p.N494KSKCM1
p.F216SHNSC1
p.P161LLGG1
p.T475AUCEC1
p.S198FSKCM1
p.P114LSKCM1
p.P26SSKCM1
p.A438VLUAD1
p.S128LSKCM1
p.R93HPRAD1
p.A580TBLCA1
p.S128LDLBC1
p.C417FLUAD1
p.W521RLGG1
p.W497RLGG1
p.P377SSKCM1
p.S43FSKCM1
p.S486LSKCM1
p.P464SSKCM1
p.S88FSKCM1
p.E452KSKCM1
p.R548KCESC1
p.Y189CPRAD1
p.E324KBLCA1
p.H351QSTAD1
p.V287IHNSC1
p.A414VSTAD1
p.E245KSKCM1
p.S159YLUAD1
p.S392*HNSC1
p.I127FSKCM1
p.N150SSKCM1
p.M327ILUAD1
p.P263AACC1
p.Q540XSKCM1
p.E318DUCEC1
p.P246RGBM1
p.M538ISKCM1
p.R230QSKCM1
p.P493SSKCM1
p.G305ESKCM1
p.T268AUCEC1
p.S208LSKCM1
p.R477HUCEC1
p.P90LSKCM1
p.Q111KLUAD1
p.W158*SKCM1
p.R555XCOAD1
p.L144ILUAD1
p.R69HPAAD1
p.S174FSKCM1
p.V263IHNSC1
p.R493KSKCM1
p.V360GSKCM1
p.Q237*SKCM1
p.R459QSKCM1
p.P212SSKCM1
p.P477LSKCM1
p.P199QREAD1
p.C592YCESC1
p.T406KLUAD1
p.P401LSKCM1
p.G141ESKCM1
p.M321LLIHC1
p.A571VBLCA1
p.R579*SKCM1
p.R19*UCEC1
p.Y303NLUAD1
p.A536VSTAD1
p.Q544RLUAD1
p.P590RLUAD1
p.N518KSKCM1
p.D459HHNSC1
p.E73DESCA1
p.E98KBLCA1
p.P65SSKCM1
p.A414VLUAD1
p.N400KBLCA1
p.I249MSTAD1
p.A447SSTAD1
p.H375YSKCM1
p.F241VCOAD1
p.G72ESKCM1
p.E221KSKCM1
p.Q213XSKCM1
p.C441SHNSC1
p.E428KSKCM1
p.C449RLUSC1
p.P577TLUAD1
p.R380CESCA1
p.W316XSKCM1
p.A571ELUAD1
p.P62SSKCM1
p.V508AGBM1
p.N238KREAD1
p.A547ELUAD1
p.E218ASTAD1
p.D35NSKCM1
p.P41SSKCM1
p.P81LSTAD1
p.M345ISARC1
p.Q237ECESC1
p.N376SBLCA1
p.P401SSKCM1
p.R356SLUSC1
p.D132NSKCM1
p.F554LUCS1
p.Q544ELUAD1
p.S61ABRCA1
p.K528QUCEC1
p.S454YOV1
p.R206QSKCM1
p.P174LSKCM1
p.S353YCOAD1
p.S550*UCEC1
p.R69HPRAD1
p.C441FLUAD1
p.Q509*SKCM1
p.F481SCHOL1
p.Q135KLUAD1
p.P344SSKCM1
p.R477CBRCA1
p.P239AACC1
p.C275*LUAD1
p.G183VLUSC1
p.T533ASTAD1
p.F241LUCEC1
p.D483HHNSC1
p.P137LLGG1
p.N376KBLCA1
p.E124DSTAD1
p.D108NSKCM1
p.F505SCHOL1
p.G329ESKCM1
p.W436*STAD1
p.S184LSKCM1
p.Q411PMESO1
p.K186*PRAD1
p.A556ECOAD1
p.E49KSKCM1
p.P62HLUSC1
p.Q520RLUAD1
p.G245RREAD1
p.K332NUCEC1
p.119_120SL>RILUAD1
p.P105LSTAD1
p.T484ALGG1
p.R548KSKCM1
p.S164GSTAD1
p.P448SSKCM1
p.P86SSKCM1
p.P273TLUSC1
p.S174YLUSC1
p.G294ECESC1
p.F578LUCS1
p.D59NSKCM1
p.P568LSKCM1
p.R356CESCA1
p.G278*THCA1
p.D38ESTAD1
p.T382KLUAD1
p.P105LLGG1
p.P453LSKCM1
p.P236SSKCM1
p.E49DESCA1
p.S143RLUAD1
p.C171SSTAD1
p.S65FSKCM1
p.Y279NLUAD1
p.I151FSKCM1
p.F32LCOAD1


Top
TissGeneCNV for CFHR5

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for CFHR5

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
Chimerdb3.0FusionScanPRADTCGA-KC-A7F3-01AZNHIT6-CFHR5Out-of-Framechr1:86167839chr1:196977616


Top
TissGeneNet for CFHR5

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
CFHR5, C3 (tumor)CFHR5, C3 (normal)
bullet pointbullet point


Top
TissGeneProg for CFHR5

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for CFHR5
TissGeneDrug for CFHR5

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for CFHR5

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0022658Kidney Diseases15BeFree
umls:C0017658Glomerulonephritis7BeFree,GAD
umls:C0268731Renal glomerular disease4BeFree
umls:C0019061Hemolytic-Uremic Syndrome3BeFree,GAD
umls:C0022661Kidney Failure, Chronic3BeFree
umls:C0242383Age related macular degeneration3BeFree,GAD
umls:C0268743Membranoproliferative Glomerulonephritis, Type II3BeFree
umls:C1561643Chronic Kidney Diseases3BeFree
umls:C2931788Atypical Hemolytic Uremic Syndrome3BeFree,GAD
umls:C0024141Lupus Erythematosus, Systemic2BeFree
umls:C0403447Chronic Kidney Insufficiency2BeFree
umls:C1305904Familial hematuria2BeFree
umls:C3714534dowling-degos disease2BeFree
umls:C0017662Glomerulonephritis, Membranoproliferative1BeFree,LHGDN
umls:C0024301Lymphoma, Follicular1BeFree
umls:C0024305Lymphoma, Non-Hodgkin1GAD
umls:C0026821Muscle Cramp1BeFree
umls:C0035078Kidney Failure1BeFree
umls:C0038395Streptococcal Infections1BeFree
umls:C0272240Disorder of complement1BeFree
umls:C0403440Thin basement membrane disease1BeFree
umls:C2316810Chronic kidney disease stage 51BeFree
umls:C2749604HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 10ORPHANET
umls:C3553720CFHR5 DEFICIENCY0CLINVAR,ORPHANET